about
Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury.Parvovirus transmission by blood products - a cause for concern?Parvovirus B19 infection after transplantation: a review of 98 cases.Parenteral transmission of the novel human parvovirus PARV4.Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humansHigh frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.Effects of human Parvovirus B19 and Bocavirus VP1 unique region on tight junction of human airway epithelial A549 cells.Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissueChanging epidemiology of human parvovirus 4 infection in sub-Saharan Africa.Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.Parvovirus-B19-associated complications in renal transplant recipients.High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy.Parvovirus b19 associated hepatitis.The expanding range of parvoviruses which infect humans.Human bocavirus-the first 5 years.Diagnosis of in utero Parvovirus B19 infection and maternal immune response - the relevance of linear epitopes and advanced serologic testing.The role of parvovirus B19 and the immune response in the pathogenesis of acute leukemia.Human Parvoviruses.Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture.Genomic features of the human bocavirusesIncreased Numbers of CD4+CD25+ and CD8+CD25+ T-Cells in Peripheral Blood of Patients with Rheumatoid Arthritis with Parvovirus B19 Infection.Infection and immunity for human parvovirus B19 in patients with febrile exanthema.Does parvovirus infection have a role in systemic lupus erythematosus?Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.Virome characterisation from Guthrie cards in children who later developed acute lymphoblastic leukaemia.Granzyme B mediated function of Parvovirus B19-specific CD4(+) T cells.Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia.The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts.Human bocavirus is not detectable in bone marrow from patients with myelodysplastic syndromes.Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates.Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells.Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients.Clinical significance of parvovirus B19 DNA in cutaneous biopsies.Analysis of porcine parvoviruses in tonsils and hearts from healthy pigs reveals high prevalence and genetic diversity in Germany.Molecular analysis of carnivore Protoparvovirus detected in white blood cells of naturally infected cats.Occurrence of human bocaviruses and parvovirus 4 in solid tissues.Identification of parvovirus in the bone marrow of eight cats.A high prevalence of parvovirus B19 DNA in patients with psoriasis.
P2860
Q30318661-25D073B5-251F-4A50-BEAF-4DDF8DD678B9Q30571511-478A6FD4-37EB-49B9-B484-7C49F2BFE2DDQ33371465-9F1A1A6A-00C4-4FDF-B6E3-CE1F9659285FQ33800906-770F639D-BBF7-4F65-9AA8-C49E3FFFBF86Q33987526-16EA9E3B-5F2F-408C-B864-6D7A1ECAE92DQ34039466-DC2D29C2-83A9-47CE-83BD-941E9171B755Q34117122-7A86BE80-1653-440C-BB66-38EBC1A04FCEQ34277090-81234D6C-F97E-4C55-A963-CB1D9DE1DAF0Q34624583-D15969CA-CBC6-406D-A171-AAF2377D9B5AQ35804598-B835EB55-A9DA-4B41-8B09-37F8B82AD190Q36184537-617E1B81-8FEA-4485-B505-E905DA3BD1D3Q36951683-D915922F-765F-4928-8D45-A76586F30190Q37051449-48E1C8C7-8DDF-4280-9C51-30EA10A84D8EQ37285923-AF8E8595-CEE7-4B7C-BB5E-E4D489FF7DA8Q37768390-20DD577D-4A15-44CF-8E05-08FC4B972A56Q37950974-B865215E-299A-4C44-B77C-D0B2BD8C909BQ38088715-B6EEED6B-436C-48AA-86DC-E6557E404DF7Q38412284-CEB5AE52-8CA9-4BEC-A531-B25FCA41E11FQ38996997-F12216C4-E8F6-4EB9-B5AF-E6E6541E9F7CQ39139921-A75464FC-CC1E-4ED6-9B84-DC6DFC4AE467Q39644951-D0BD9196-D750-427B-9103-C00D45D1CEC2Q40266903-3BAF8118-889C-4629-934B-D69C177056F9Q40321614-B9B09EC8-848D-4367-A669-1DCED53B308EQ40360576-2320FDC5-54B0-4BD6-9E44-F2054FBBA672Q40430043-F9D6170A-DFB4-4991-926A-5746528705AAQ40566146-F17E6C77-715C-4A85-9564-44DE21FDEA14Q40655396-474F859A-EAAD-4837-AE7D-3BE43463C7D1Q41868019-E92E950D-07A6-4ECD-9F79-A5AAC6193FDFQ41932837-ADC89B41-8561-4649-9403-162DB4F337BEQ42221396-2FE8ABE7-B079-45BA-80A9-472D9D0EE256Q43186540-8E1B7AA1-A1FD-4D3C-930A-A06432926740Q43461065-D23E6335-5C86-4EFD-9CFA-D78CC3CEBD9AQ45061283-A1BAB83E-03C2-43CF-8940-F8D0700DE86CQ47147160-21CB1B39-18FA-4D28-A990-280FE49A951DQ47606050-1F167066-1A42-432B-99DD-085610D1548EQ48041231-FC51BC3F-00A7-4530-B2BC-3C242FDBB6F2Q48103895-582F5B14-BF2F-4CC2-B087-067480394DA7Q54304445-613CA15D-6A61-45A6-A0B0-313EE60F31D2Q54317808-956196D3-4926-4080-9FE5-E99A4D70ECA1Q54590945-59744762-FB80-4BC1-B504-0539BD09BCD5
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Persistence of human parvovirus B19 in human tissues.
@ast
Persistence of human parvovirus B19 in human tissues.
@en
Persistence of human parvovirus B19 in human tissues.
@nl
type
label
Persistence of human parvovirus B19 in human tissues.
@ast
Persistence of human parvovirus B19 in human tissues.
@en
Persistence of human parvovirus B19 in human tissues.
@nl
prefLabel
Persistence of human parvovirus B19 in human tissues.
@ast
Persistence of human parvovirus B19 in human tissues.
@en
Persistence of human parvovirus B19 in human tissues.
@nl
P2093
P1476
Persistence of human parvovirus B19 in human tissues.
@en
P2093
Henna Rautakorpi
Janne Nieminen
Kati Hokynar
P304
P356
10.1016/S0369-8114(02)00307-3
P577
2002-06-01T00:00:00Z